183 related articles for article (PubMed ID: 31346082)
1. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
Wong JP; Stuhlmiller TJ; Giffin LC; Lin C; Bigi R; Zhao J; Zhang W; Bravo Cruz AG; Park SI; Earp HS; Dittmer DP; Frye SV; Wang X; Johnson GL; Damania B
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16541-16550. PubMed ID: 31346082
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.
He M; Tan B; Vasan K; Yuan H; Cheng F; Ramos da Silva S; Lu C; Gao SJ
J Pathol; 2017 Jul; 242(3):309-321. PubMed ID: 28393364
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.
Roy D; Dittmer DP
Am J Pathol; 2011 Oct; 179(4):2108-19. PubMed ID: 21819957
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma.
Bhatt AP; Jacobs SR; Freemerman AJ; Makowski L; Rathmell JC; Dittmer DP; Damania B
Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11818-23. PubMed ID: 22752304
[TBL] [Abstract][Full Text] [Related]
8. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
10. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.
White MC; Wong JP; Damania B
Cancer Res Commun; 2024 Apr; 4(4):1024-1040. PubMed ID: 38592451
[TBL] [Abstract][Full Text] [Related]
13. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
14. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract][Full Text] [Related]
18. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
Ishikawa C; Mori N
Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
[TBL] [Abstract][Full Text] [Related]
20. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
